|
|  |
E-mail Alerts Signup - receive headline stories by email.
| | May 6, 2008 | Medarex to Present at the Bank of America 2008 Healthcare Conference |
| Apr 29, 2008 | Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology |
| Apr 25, 2008 | Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab |
| Apr 22, 2008 | Medarex to Present at the Morgan Stanley Global Healthcare Unplugged Conference |
| Apr 16, 2008 | Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting |
| Apr 16, 2008 | Medarex Reports Preclinical Data on Multiple Antibody-Drug Conjugate Candidates at American Association for Cancer Research Meeting |
| Apr 15, 2008 | Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting |
| Apr 3, 2008 | Medarex Announces Ipilimumab Program Continues to Move Forward |
| Mar 31, 2008 | Medarex to Receive Milestone Payment from Novo Nordisk |
| Mar 20, 2008 | Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis |
| Mar 17, 2008 | Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research |
| Feb 28, 2008 | Medarex to Present at the Susquehanna Financial Group Healthcare Conference |
| Feb 26, 2008 | Medarex Announces 2007 Fourth Quarter and Year End Financial Results |
| Feb 20, 2008 | Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008 |
| Feb 1, 2008 | Medarex Announces Completion of Sale of Shares in Genmab A/S |
| Jan 31, 2008 | Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference |
| Jan 24, 2008 | Medarex to Present at the 2008 Wachovia Healthcare Conference |
| Jan 8, 2008 | Medarex Announces Allowance of Investigational New Drug Application for Wholly Owned Fully Human Anti-CD70 Antibody, MDX-1411 |
| Jan 8, 2008 | PharmAthene and Medarex Announce FY 2008 U.S. Congressional Appropriation of up to $1.6 Million for Continued Development of Anthrax Therapeutic Valortim(TM) |
| Jan 3, 2008 | Medarex to Present at the 26th Annual JPMorgan Healthcare Conference |
Archived 2007 Press Releases
Archived 2006 Press Releases
Archived 2005 Press Releases
Archived 2004 Press Releases
Archived 2003 Press Releases
Archived 2002 Press Releases
Archived 2001 Press Releases
Archived 2000 Press Releases
Archived 1999 Press Releases
Archived 1998 Press Releases
Archived 1997 Press Releases
©2001-2008 Medarex, Inc. All rights reserved. - Legal Disclaimer - Trademarks - Privacy Policy
| |
